在心脏性休克并发症急性心肌梗塞的早期再血管和长期存活
Judith S Hochman1, Lynn A Sleeper, John G Webb
1Cardiovascular Clinical Research Center, New York University School of Medicine, New York 10016, USA. judith.hochman@med.nyu.edu
JAMA
|June 8, 2006
概括
早期的重血管化显著改善了急性心肌梗塞患者的长期存活率,这些患者患有心脏性休克. 与初始医疗稳定相比,这种策略在六年内提供了67%的相对存活率改善.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 关键护理医学 关键护理医学
背景情况:
- 心脏性休克 (CS) 是急性心肌梗塞 (MI) 患者的主要死亡原因.
- 虽然早期再血管化的1年生存率更高,但长期数据有限.
- 在SHOCK试验中,研究了早期再血管化的长期影响,在CS中复杂化急性心脏病发作.
研究的目的:
- 评估早期再血管化对CS急性肌痛性心脏病患者长期存活率的影响.
- 为了比较早期复血管化和初始医疗稳定策略之间的长期结果.
主要方法:
- 国际随机化SHOCK试验招募了302名患有急性心脏病发作并发症的患者.
- 患者被随机分配到早期的再血管化或初始的医疗稳定.
- 长期生命状态随访每年进行,直到2005年 (1-11年).
主要成果:
- 在1年早期重血管化13%的生存优势在6年持续 (32.8%对19.6%).
- 早期的再血管化在6年内显示出显著的生存益处 (HR0.74,P=.03).
- 在医院幸存者中,早期再血管化 (62.4%对44.4%) 的6年生存率更高.
结论:
- 早期的再血管化显著改善了CS急性MI患者的6年生存率.
- 这一策略导致6年生存率的绝对改善为13.2%,相对改善为67%.
- 建议对急性心脏病发作患者进行早期的再血管化,这些患者由于左心室衰竭而患有CS.
更多相关视频
14:35Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
06:10Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
相关概念视频
01:30Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...